3,435 results on '"Cancer survivor"'
Search Results
2. Prognostic Effect of Body Composition in Cancer Survivors
- Author
-
Lei Liu, Director
- Published
- 2024
3. Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostate Cancer Survivors
- Published
- 2024
4. Yoga, Survivorship Health Education, and Cognitive Behavioral Therapy in Reducing Insomnia in Cancer Survivors (YOCAS-II)
- Author
-
National Cancer Institute (NCI) and Karen Mustian, Professor
- Published
- 2024
5. Self-applied Acupressure for Arthralgia-fatigue-sleep Disturbance in Breast Cancer
- Author
-
The Huazhong University of Science and Technology Union Shenzhen Hospital and Dr CHENG Huilin, Assistant Professor
- Published
- 2024
6. Lifestyle Intervention for the Reduction of Prostate Cancer Disparities Among African Americans
- Author
-
Brander Beacons Cancer Research and National Cancer Institute (NCI)
- Published
- 2024
7. Characterizing Fatigue Experienced by Cancer Patients Receiving Primary Treatment and Cancer Survivors
- Published
- 2024
8. Manual Therapy in Treating Fibrosis-Related Late Effect Dysphagia in Head and Neck Cancer Survivors (MANTLE)
- Author
-
National Cancer Institute (NCI)
- Published
- 2024
9. Exercise and Diet Counseling Program in Improving Quality of Life in Stage I-III Breast Cancer Survivors
- Author
-
Brian Focht, Principal Investigator
- Published
- 2024
10. Survivorship Care Planning in Improving the Quality of Life in Breast Cancer Survivors
- Author
-
National Cancer Institute (NCI)
- Published
- 2024
11. Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family Members
- Author
-
National Cancer Institute (NCI)
- Published
- 2024
12. Personalized Dietary Intervention in Managing Bowel Dysfunction and Improving Quality of Life in Stage I-III Rectosigmoid Cancer Survivors
- Author
-
National Cancer Institute (NCI) and Hope Foundation
- Published
- 2024
13. Long-Term Follow-Up in Patients With Prostate Cancer After Surgery
- Author
-
National Cancer Institute (NCI)
- Published
- 2024
14. Lifestyle Behavior Influences Among African American Patients With Stage 0-III Prostate Cancer Survivors and Their Partners
- Author
-
National Cancer Institute (NCI)
- Published
- 2024
15. Increasing the Dose of Survivorship Care Planning in Improving Care and Outcomes in Prostate Cancer Survivors Receiving Androgen Deprivation Therapy
- Author
-
National Cancer Institute (NCI)
- Published
- 2024
16. Educational and occupational aspirations of adolescent and young adult cancer survivors: a qualitative analysis.
- Author
-
Rao, Pooja, Segel, Joel E., Bingen, Kristin, Devine, Katie A., Rumbaugh, Courtney L., Costigan, Heather J., Dandekar, Smita, Wasserman, Emily, Koehly, Laura M., Blackall, George F., Rakszawski, Kevin, Songdej, Natthapol, Verdery, Ashton M., Lengerich, Eugene J., and Van Scoy, Lauren J.
- Abstract
Purpose: Adolescent and young adult cancer survivors (AYACS) are patients diagnosed with cancer between 15 and 39 years of age. AYACS are often derailed from planned educational and occupational endeavors due to disruption from cancer treatment and its consequences. The study objective was to examine how a personal cancer diagnosis impacted AYACS’ experiences related to these endeavors. Methods: Semi-structured interviews were conducted as part of a larger study assessing psychosocial challenges among a younger AYACS subset aged 15–25 years old at the time of cancer diagnosis. Interviews were coded based on responses and were used to develop themes related to educational and occupational endeavors. Results: Data were collected from 35 participants. Five themes emerged: (1) Pauses in educational attainment had a detrimental effect on educational goals for some participants, but further solidified and sculpted educational plans for others; (2) Although participants experienced challenges accomplishing educational goals, supportive school environments helped surmount these challenges; (3) Participants reflected on rethinking career aspirations, though some desired to pursue the same occupation planned before cancer diagnosis; (4) Participants experienced challenges, including physical and cognitive limitations, upon returning to work; and (5) Participants valued autonomy and normalcy through work and appreciated supportive and flexible work environments. Conclusions: AYACS prioritize professional achievement, yet encounter challenges in achieving professional goals. Our findings create a foundation for developing and testing prospective interventions to promote continuance of school and work during cancer treatment when feasible, and proactive reintegration strategies for those who paused professional goals due to cancer treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. The efficacy of cognitive behavioral therapy for mental health and quality of life among individuals diagnosed with cancer: A systematic review and meta‐analysis.
- Author
-
Dils, Alexander T., O'Keefe, Kathryn, Dakka, Nada, Azar, Michelle, Chen, Meiyan, and Zhang, Anao
- Subjects
- *
COGNITIVE therapy , *CANCER survivors , *CLINICAL trials , *CANCER patients , *QUALITY of life - Abstract
Objective: It has long been documented that cognitive behavioral therapy (CBT) has positive impacts on improving mental health (MH) and quality of life (QoL) in the general population, but investigations on its effect on cancer survivors remain limited, especially for QoL outcomes. The purpose of this meta‐analysis is to investigate the effects of CBT as compared to control on cancer patients' MH and QoL outcomes. Control is defined in this study as standard therapy, waitlist control, and active/alternative therapy. Methods: In total, 154 clinical trials creating a sample size of 1627 individuals were collected. Analysis focusing on MH and QoL excluded 29 clinical trials resulting in a final analysis of 132 clinical trials (and 1030 effect sizes). R Statistical Software (version 4.2.2) and the robumeta package were utilized to complete analysis, which entailed robust variance estimation (RVE) in intercept‐only meta‐regression, and univariate meta‐regression (for moderator analysis). Results: Across 132 clinical trials and 1030 effect size estimates, we identified that CBT moderately improves MH and QoL in cancer patients d = 0.388, 95% CI 0.294–0.483, p < 0.001. Additionally, age and delivery format can influence the efficacy of CBT in this patient population. Conclusions: CBT statistically improves the MH and QoL psychosocial parameters in cancer patients with greater efficacy in younger patients. Important clinical and intervention‐related factors, that is, age and delivery, should be considered when oncologists consider CBT as a psychotherapeutic intervention for individuals with cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. Association between physical activity changes and risk of incident ischemic stroke following cancer diagnosis: A nationwide retrospective cohort study.
- Author
-
Jung, Wonyoung, Cho, In Young, Jung, Jinhyung, Cho, Mi Hee, Koo, Hye Yeon, Park, Yong‐Moon Mark, Cho, Be‐Long, Kwon, Hyuktae, Park, Jin Ho, Han, Kyungdo, and Shin, Dong Wook
- Subjects
- *
ISCHEMIC stroke , *PHYSICAL activity , *CANCER diagnosis , *NATIONAL health insurance , *SEDENTARY behavior , *CARDIOVASCULAR diseases , *STROKE - Abstract
Background: Physical inactivity is prevalent after cancer treatment, which could increase ischemic stroke risk in cancer survivors. This study investigated the association between physical activity change from pre‐ to post‐diagnosis and ischemic stroke risk among cancer survivors. Methods: Using data from the Korean National Health Insurance Service database, 269,943 cancer survivors (mean [SD] age, 56.3 [12.1] years; 45.7% male) with no history of cardiovascular disease were evaluated based on changes in physical activity from pre‐ to post‐diagnosis. Using the Fine‐Gray model, subdistribution hazard ratios (sHRs) and 95% confidence intervals (CIs) for ischemic stroke risk were calculated, considering death as a competing risk. Results: After cancer diagnosis, 62.0% remained inactive, 10.1% remained active, 16.6% became active, and 11.4% became inactive. During a mean (SD) follow‐up of 4.1 (2.0) years, being active both pre‐ and post‐diagnosis was associated with a 15% decreased risk of ischemic stroke (sHR, 0.85; 95% CI, 0.75–0.96), compared with those who remained inactive. Cancer survivors who became active and inactive post‐diagnosis showed a 16% and 11% lower ischemic stroke risk (sHR, 0.84; 95% CI, 0.75–0.93; sHR, 0.89; 95% CI, 0.79–0.99), respectively, than those who remained inactive. Analysis by the primary cancer site did not substantially differ from the main findings. Conclusions: Physical activity is associated with reduced ischemic stroke risk among cancer survivors. The potential benefits of physical activity are not limited to individuals who were physically active before cancer diagnosis, thus preventive strategies against ischemic stroke should emphasize physical activity throughout the cancer journey. In this nationwide cohort study of 269,943 cancer survivors from Korea, maintaining regular physical activity before and after diagnosis was associated with a 15% decrease in the risk of ischemic stroke. The potential benefits of physical activity are not limited to individuals who were physically active before their diagnosis, so it is not too late to start after a cancer diagnosis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
19. Effect of the 2024 Noto Peninsula earthquake on outpatient chemotherapy among cancer survivors in Japan: a retrospective study.
- Author
-
Kitamura, Yoshiko, Nakai, Hisao, Naruse, Ikumo, Yazaki, Miku, Maekawa, Yukie, and Yasumoto, Kazuo
- Subjects
- *
CANCER chemotherapy , *EARTHQUAKES , *DISASTER victims , *CANCER survivors , *NURSING records - Abstract
Background: The study aim was to elucidate the effect of the 2024 Noto Peninsula earthquake on outpatient chemotherapy treatment of cancer survivors at Kanazawa Medical University Hospital (KMUH), Japan. Methods: Medical and nursing records for January 4–31, 2024, from KMUH were retrospectively collected, and data for 286 participants were analyzed. Results: Of the 286 participants, 95.1% were able to attend their first scheduled appointment. Of the 12 (4.2%) who could not attend because of the earthquake, 7 (58.3%) rescheduled their appointments. A total of 8 participants (2.8%) were unable to attend their second scheduled appointment in January, despite being able to attend their first appointment; 3 (37.5%) of these participants reported that they were unable to attend their appointments because of the effect of the earthquake. Chemotherapy was not administered to 53 (18.5%) participants who did attend, mainly owing to neutropenia, progressive disease, rash, and anemia. Evacuation information was available for 25 participants (8.7%); of these, 8 (28.6%) evacuated to their homes, 7 (25.0%) to public shelters, and 4 (14.3%) to apartments near the hospital. Disaster status information was obtained from 62 participants (21.7%), and indicated experiences such as home damage, water outages, and relying on transportation assistance from family to attend appointments. Conclusions: Most cancer survivors receiving chemotherapy at KMUH were able to maintain outpatient visits. However, a few could not attend because of the earthquake. Further studies are needed to provide more detailed information on the effect of disasters on cancer survivors and the potential factors underlying non-attendance at medical appointments. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
20. Correlates of smoking during COVID-19 in the LGBTQI + cancer survivor population.
- Author
-
Maglalang, Dale Dagar, Lyerly, Reece, Scout, NFN, Avila, Jaqueline C., and Ahluwalia, Jasjit S.
- Abstract
Purpose: Stressors brought on by the pandemic may have further encouraged lesbian, gay, bisexual, transgender, queer, and intersex plus (LGBTQI +) cancer survivors to smoke. The purpose of this study is to examine factors associated with smoking among LGBTQI + cancer survivors during the pandemic. Methods: We used a secondary data analysis of OUT: The National Cancer Survey. We conducted logistic regression analysis to examine the associations between psychological distress, binge drinking, and socio-demographic factors with ever use and current use of cigarettes, other tobacco, and nicotine products. Results: Of the 1629 participants in our sample, 53% used in their lifetime and 13% reported current use. Correlates of increased ever use included being of older age (AOR = 1.02; 95% CI: 1.01, 1.03) and binge drinking (AOR = 2.47; 95% CI: 1.17, 5.20) while correlates of decreased ever use were among those with a graduate or professional degree (AOR = 0.40; 95% CI: 0.23, 0.71). Correlates of increased current use included being of Latine descent (AOR = 1.89; 95% CI: 1.07, 3.36), binge drinking (AOR = 3.18; 95% CI: 1.56, 6.48), without health insurance (AOR = 2.37; 95% CI: 1.10, 5.10), and being disabled (AOR = 1.64; 95% CI: 1.19, 2.26) while correlates of decreased current use were among cisgender women (AOR = 0.30; 95% CI: 0.12, 0.77), being of younger age (AOR = 0.98; 95% CI: 0.96, 0.99), and having a graduate or professional degree (AOR = 0.33; 95% CI: 0.15, 0.70). Conclusions: Our findings demonstrate that a proportion of LGBTQI + cancer survivors continue to smoke during the pandemic despite the increased risk involved with smoking. Furthermore, individuals with intersecting marginalized identities experience additional stressors that may have been further exacerbated by the conditions of the pandemic that encourage them to smoke. Implications for Cancer Survivors: Quitting smoking after a cancer diagnosis can decrease the chances of recurrence and a new primary malignancy. In addition, practitioners and researchers should advocate towards examining and addressing systemic forms of oppression in institutions that LGBTQI + cancer survivors navigate during the pandemic. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
21. Acceptance and Commitment Therapy in the Transdiagnostic Treatment of a Breast Cancer Survivor: A Case Study1.
- Author
-
Sakai, Mie, Kondo, Masaki, Sugiura, Takeshi, and Akechi, Tatsuo
- Subjects
- *
ACCEPTANCE & commitment therapy , *HABIT , *CANCER survivors , *POSTOPERATIVE pain , *BREAST cancer , *JOB absenteeism - Abstract
We describe a case report on acceptance and commitment therapy (ACT) for a breast cancer survivor with chronic postsurgical pain, fear of cancer recurrence, and depression. As part of multidisciplinary therapy at the pain center, 17 sessions of ACT and two follow‐up sessions were provided over approximately 6 months. Outcome measures (chronic pain and fear of cancer recurrence) and process measures (pain acceptance and valued action) were assessed. Outcome measures, including pain intensity, interference, quality of life, and fear of cancer recurrence, and ACT process measures improved after the intervention and at follow‐up sessions compared to baseline. Over the treatment course, depression symptoms worsened, which necessitated a leave of absence from work for several months, during which time the patient engaged in intensive ACT. Ultimately, the patient returned to work, resumed her hobbies, and acquired a new habit of exercising, demonstrating changes to her lifestyle as well. The results support the efficacy of ACT in patients with multiple psychological and physical symptoms. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
22. The Impact of Pain Education Interventions for Cancer Survivors and Caregivers: A Systematic Review with Meta-Analysis.
- Author
-
Hernández-Hernández, Sofía, Heredia-Ciuró, Alejandro, Martín-Núñez, Javier, Calvache-Mateo, Andrés, Navas-Otero, Alba, López-López, Laura, and Valenza, Marie Carmen
- Subjects
- *
RISK assessment , *RESEARCH funding , *CINAHL database , *CANCER patients , *TREATMENT effectiveness , *META-analysis , *RANDOMIZED controlled trials , *CAREGIVERS , *CANCER pain , *SYSTEMATIC reviews , *MEDLINE , *PAIN , *TUMORS , *ONLINE information services , *DISEASE complications - Abstract
Simple Summary: Implementing educational programs for patients and their caregivers has been suggested as an effective method to help alleviate pain associated with cancer. The purpose of this study was to compile and review the current pain education interventions for cancer patients and their caregivers using a standardized methodological approach, and to evaluate the impact of these interventions on pain. These findings are significant for healthcare professionals as they provide a foundation for motivating cancer patients to engage actively in their treatment. Implementing these results could save time and resources for healthcare providers, thereby enhancing the quality of treatments. Introduction: Cancer-related pain is a global health-related problem associated with functional impairment, anxiety, depression, and reduced quality of life. The use of educational interventions for patients and their caregivers has been proposed as a promising tool for overcoming pain in cancer. The aim of this study was to summarize by means of a standardized methodological systematic revision the actual pain education intervention used in cancer patients and their caregivers and to analyze its effects on pain. Methods: A search was conducted through PubMed, Web of Science, Scopus and Cinhal from their inception to September 2022. Randomized controlled trials which included pain education interventions were identified. Two reviewers performed independent data extraction and methodologic quality assessments of these studies. Results: A total of seven studies was included in the study. The meta-analysis showed that pain education interventions have a significant effect on the worst pain; however, there was no effect on average pain. Conclusions: Pain education interventions addressed to patients and their caregivers could have positive effects on cancer-related pain. It is recommended that a minimum of three sessions of about one hour's duration be held once a week. Further research needs to be carried out and analyzed on the effects over the long term. Pain education interventions show positive results in improving pain in cancer patients regardless of etiology or extent of the cancer. Studies with better methodological quality should be carried out to address specific components related to education interventions. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
23. Sociodemographic Correlates of Low Health Literacy Skills Among Cancer Survivors: National Findings From BRFSS 2016.
- Author
-
Chen, Qi, Moore, John, Noel, Lailea, von Sternberg, Kirk, and Jones, Barbara
- Subjects
- *
INFORMATION-seeking behavior , *HEALTH literacy , *INCOME , *INFORMATION literacy , *SECONDARY analysis - Abstract
Purpose: This study aimed to explore associations of sociodemographic factors with difficulties in three health literacy (HL) skills and the severity of low HL skills. Design: Cross-sectional secondary data analysis. Subjects: Data came from 17,834 adults who responded to the HL module with a response rate of 47% in the 2016 Behavioral Risk Factor Surveillance System. Measures: Independent variables included sex, age, race/ethnicity, education, employment and income. Dependent variables are three HL skills: obtaining, understanding oral, and understanding written health information. Analysis: We conducted weighted Chi-square tests and multinominal logistic regressions. Results: Cancer survivors younger than 65 (aged 18-39: AOR = 4.46, P <.001; aged 40-64: AOR = 2.29, P <.001), Hispanic (AOR = 2.17, CI = 1.61-2.50, P <.01) had higher odds of difficulty obtaining health information. Female cancer survivors had lower odds of difficulty comprehending oral (AOR =.69, CI =.55-.87, P <.01) and written (AOR =.58, CI =.46-.74, P <.001) information. The relative risk ratio of having difficulties in three HL tasks was higher for those who were younger than 65 (aged 18-39: RRR = 10.18, CI = 2.41-4.3, P <.01; aged 40-64: RRR = 4.01, CI = 2.09-7.69, P <.001), Hispanic (RRR = 3.24, CI = 1.66-11.34, P <.01), unemployed (RRR = 6.1, CI = 2.88-12.76, P <.001), education levels lower than some college (some high school: RRR = 4.34, P <.01; high school: RRR = 2.62, P <.05) and household income under $25,000 (RRR = 6.99, CI = 2.8-17.5, P <.001). Conclusion: Intervention and communication materials need to be tailored for patients with different HL skills considering age, gender, socioeconomic status and cultural backgrounds. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
24. A qualitative study of stakeholders' experiences with and acceptability of a technology‐supported health coaching intervention (SHARE‐S) delivered in coordination with cancer survivorship care.
- Author
-
Price, Sarah N., Houston, Thomas K., Sadasivam, Rajani S., Wentworth, Stacy, Chandler, Allison, Strahley, Ashley, Kittel, Carol, Balakrishnan, Kavitha, Weaver, Kathryn E., Dellinger, Rebecca, Puccinelli‐Ortega, Nicole, Kong, Jinhee, Cutrona, Sarah L., Foley, Kristie L., and Sohl, Stephanie J.
- Subjects
- *
HEALTH coaches , *CANCER treatment , *HEALTH care teams , *HEALTH behavior , *TEXT messages , *MEDICAL care accountability - Abstract
Purpose: Healthy cancer survivorship involves patients' active engagement with preventative health behaviors and follow‐up care. While clinicians and patients have typically held dual responsibility for activating these behaviors, transitioning some clinician effort to technology and health coaches may enhance guideline implementation. This paper reports on the acceptability of the Shared Healthcare Actions & Reflections Electronic systems in survivorship (SHARE‐S) program, an entirely virtual multicomponent intervention incorporating e‐referrals, remotely‐delivered health coaching, and automated text messages to enhance patient self‐management and promote healthy survivorship. Methods: SHARE‐S was evaluated in single group hybrid implementation‐effectiveness pilot study. Patients were e‐referred from the clinical team to health coaches for three health self‐management coaching calls and received text messages to enhance coaching. Semi‐structured qualitative interviews were conducted with 21 patient participants, 2 referring clinicians, and 2 health coaches to determine intervention acceptability (attitudes, appropriateness, suitability, convenience, and perceived effectiveness) and to identify important elements of the program and potential mechanisms of action to guide future implementation. Results: SHARE‐S was described as impactful and convenient. The nondirective, patient‐centered health coaching and mindfulness exercises were deemed most acceptable; text messages were less acceptable. Stakeholders suggested increased flexibility in format, frequency, timing, and length of participation, and additional tailored educational materials. Patients reported tangible health behavior changes, improved mood, and increased accountability and self‐efficacy. Conclusions: SHARE‐S is overall an acceptable and potentially effective intervention that may enhance survivors' self‐management and well‐being. Alterations to tailored content, timing, and dose should be tested to determine impact on acceptability and outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
25. Acceptance and Commitment Therapy in the Transdiagnostic Treatment of a Breast Cancer Survivor: A Case Study1.
- Author
-
Sakai, Mie, Kondo, Masaki, Sugiura, Takeshi, and Akechi, Tatsuo
- Subjects
ACCEPTANCE & commitment therapy ,HABIT ,CANCER survivors ,POSTOPERATIVE pain ,BREAST cancer ,JOB absenteeism - Abstract
We describe a case report on acceptance and commitment therapy (ACT) for a breast cancer survivor with chronic postsurgical pain, fear of cancer recurrence, and depression. As part of multidisciplinary therapy at the pain center, 17 sessions of ACT and two follow‐up sessions were provided over approximately 6 months. Outcome measures (chronic pain and fear of cancer recurrence) and process measures (pain acceptance and valued action) were assessed. Outcome measures, including pain intensity, interference, quality of life, and fear of cancer recurrence, and ACT process measures improved after the intervention and at follow‐up sessions compared to baseline. Over the treatment course, depression symptoms worsened, which necessitated a leave of absence from work for several months, during which time the patient engaged in intensive ACT. Ultimately, the patient returned to work, resumed her hobbies, and acquired a new habit of exercising, demonstrating changes to her lifestyle as well. The results support the efficacy of ACT in patients with multiple psychological and physical symptoms. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
26. Use and impact of virtual resources for peer support by young adults living with cancer: A systematic review.
- Author
-
Martens, Riley, Hou, Mary, Isherwood, Susan, Hunter-Smith, Alison, Quan, May-Lynn, and Cuthbert, Colleen
- Subjects
MEDICAL information storage & retrieval systems ,CENTER for Epidemiologic Studies Depression Scale ,RESEARCH funding ,AFFINITY groups ,CINAHL database ,QUESTIONNAIRES ,INTERVIEWING ,ONLINE social networks ,SYSTEMATIC reviews ,MEDLINE ,THEMATIC analysis ,MEDICAL databases ,RESEARCH methodology ,TUMORS ,SOCIAL support ,ADULTS - Abstract
Copyright of Canadian Oncology Nursing Journal is the property of Pappin Communications and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2024
- Full Text
- View/download PDF
27. Effect of the 2024 Noto Peninsula earthquake on outpatient chemotherapy among cancer survivors in Japan: a retrospective study
- Author
-
Yoshiko Kitamura, Hisao Nakai, Ikumo Naruse, Miku Yazaki, Yukie Maekawa, and Kazuo Yasumoto
- Subjects
Cancer survivor ,2024 Noto Peninsula earthquake ,Chemotherapy ,Outpatient ,Japan ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background The study aim was to elucidate the effect of the 2024 Noto Peninsula earthquake on outpatient chemotherapy treatment of cancer survivors at Kanazawa Medical University Hospital (KMUH), Japan. Methods Medical and nursing records for January 4–31, 2024, from KMUH were retrospectively collected, and data for 286 participants were analyzed. Results Of the 286 participants, 95.1% were able to attend their first scheduled appointment. Of the 12 (4.2%) who could not attend because of the earthquake, 7 (58.3%) rescheduled their appointments. A total of 8 participants (2.8%) were unable to attend their second scheduled appointment in January, despite being able to attend their first appointment; 3 (37.5%) of these participants reported that they were unable to attend their appointments because of the effect of the earthquake. Chemotherapy was not administered to 53 (18.5%) participants who did attend, mainly owing to neutropenia, progressive disease, rash, and anemia. Evacuation information was available for 25 participants (8.7%); of these, 8 (28.6%) evacuated to their homes, 7 (25.0%) to public shelters, and 4 (14.3%) to apartments near the hospital. Disaster status information was obtained from 62 participants (21.7%), and indicated experiences such as home damage, water outages, and relying on transportation assistance from family to attend appointments. Conclusions Most cancer survivors receiving chemotherapy at KMUH were able to maintain outpatient visits. However, a few could not attend because of the earthquake. Further studies are needed to provide more detailed information on the effect of disasters on cancer survivors and the potential factors underlying non-attendance at medical appointments.
- Published
- 2024
- Full Text
- View/download PDF
28. Use and impact of virtual resources for peer support by young adults living with cancer: A systematic review
- Author
-
Riley Martens, Mary Hou, Susan Isherwood, Alison Hunter-Smith, May-Lynn Quan, and Colleen Cuthbert
- Subjects
young adult ,social support ,cancer survivor ,social survivorship ,social media ,internet-based intervention ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Background: Young adults (YA) with cancer often have unmet psychosocial needs. The impact of peer support delivered in an online format to fulfil these needs in the populations of YA with cancer has not been thoroughly examined. Methods: We searched Cochrane Central Register of Controlled Trials, CINAHL, Embase, and Medline databases. We included articles about online peer support interventions for YA cancer survivors between the ages of 18 to 40 years old. Results: Our literature search yielded n = 2,773 articles and we obtained consensus on 12 articles for inclusion. We qualitatively synthesized these articles using data abstraction based on the Template for Intervention and Replication (TIDierR) checklist. Overall, six studies demonstrated correlation between online peer support and improved wellbeing of participants. Thus, online peer support may be useful for young cancer patients. Conclusion: This systematic review summarizes the current state of knowledge regarding the availability and evaluation of online YA peer support programs and reveals the need for further research in this field.
- Published
- 2024
- Full Text
- View/download PDF
29. Health and Recovery Program in Increasing Physical Activity Level in Stage IA-IIIA Endometrial Cancer Survivors
- Published
- 2023
30. Left Ventricle Size Correlates with Peak Exercise Capacity in Pediatric Cancer Survivors Exposed to Anthracycline Chemotherapy.
- Author
-
Masood, Imran Ross, Rezvan, Panteha Hayati, Lee, Kyuwan, Vervaet, Helena, Kuo, Christopher, Loss, Karla, Menteer, JonDavid, Souza, Andrew, Freyer, David, and Su, Jennifer A.
- Abstract
Cancer survivors exposed to anthracycline chemotherapy are at risk for developing cardiomyopathy, which may have delayed clinical manifestation. In a retrospective cross-sectional study, we evaluated the utility of cardiopulmonary exercise testing (CPET) for detecting early cardiac disease in 35 pediatric cancer survivors by examining the associations between peak exercise capacity (measured via percent predicted peak VO2) and resting left ventricular (LV) function on echocardiography and cardiac magnetic resonance imaging (cMRI). We additionally assessed the relationships between LV size on resting echocardiography or cMRI and percent predicted peak VO2 since LV growth arrest can occur in anthracycline-exposed patients prior to changes in LV systolic function. We found reduced exercise capacity in this cohort, with low percent predicted peak VO2 (62%, IQR: 53–75%). While most patients in our pediatric cohort had normal LV systolic function, we observed associations between percent predicted peak VO2 and echocardiographic and cMRI measures of LV size. These findings indicate that CPET may be more sensitive in manifesting early anthracycline-induced cardiomyopathy than echocardiography in pediatric cancer survivors. Our study also highlights the importance of assessing LV size in addition to function in pediatric cancer survivors exposed to anthracyclines. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
31. Infrared laser moxibustion for cancer-related fatigue in breast cancer survivors: a randomized controlled trial
- Author
-
Huijuan Mao, Ming Jin, Lulu Xie, Ni Mao, Xubo Shen, Junchao Chen, Xuefen Chen, Jun J. Mao, and Xueyong Shen
- Subjects
Acupuncture ,Moxibustion ,Infrared laser ,Cancer-related fatigue ,Breast cancer ,Cancer survivor ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background Cancer-related fatigue (CRF) is a pervasive, persistent, and distressing symptom experienced by cancer patients, for which few treatments are available. We investigated the efficacy and safety of infrared laser moxibustion (ILM) for improving fatigue in breast cancer survivors. Methods A three-arm, randomized, sham-controlled clinical trial (6-week intervention plus 12-week observational follow-up) was conducted at a tertiary hospital in Shanghai, China. The female breast cancer survivors with moderate to severe fatigue were randomized 2:2:1 to ILM (n = 56) sham ILM (n = 56), and Waitlist control (WLC)(n = 28) groups. Patients in the ILM and sham ILM (SILM) groups received real or sham ILM treatment, 2 sessions per week for 6 weeks, for a total of 12 sessions. The primary outcome was change in the Brief Fatigue Inventory (BFI) score from baseline to week 6 with follow-up until week 18 assessed in the intention-to-treat population. Results Between June 2018 and July 2021, 273 patients were assessed for eligibility, and 140 patients were finally enrolled and included in the intention-to-treat analysis. Compared with WLC, ILM reduced the average BFI score by 0.9 points (95% CI, 0.3 to 1.6, P = .007) from baseline to week 6, with a difference between the groups of 1.1 points (95% CI, 0.4 to 1.8, P = .002) at week 18. Compared with SILM, ILM treatment resulted in a non-significant reduction in the BFI score (0.4; 95% CI, -0.2 to 0.9, P = .206) from baseline to week 6, while the between-group difference was significant at week 18 (0.7; 95% CI, 0.2 to 1.3, P = .014). No serious adverse events were reported. Conclusion While ILM was found to be safe and to significantly reduce fatigue compared with WLC, its promising efficacy against the sham control needs to be verified in future adequately powered trials. Trial registration Clinicaltrials.gov: NCT04144309. Registered 12 June 2018.
- Published
- 2024
- Full Text
- View/download PDF
32. Study protocol for a pragmatic randomised controlled trial of comparing enhanced acceptance and commitment therapy plus (+) added to usual aftercare versus usual aftercare only, in patients living with or beyond cancer: SUrvivors’ Rehabilitation Evaluation after CANcer (SURECAN) trial
- Author
-
Imran Khan, Stephanie J. C. Taylor, Clare Robinson, Elisavet Moschopoulou, Paul McCrone, Liam Bourke, Mohamed Thaha, Kamaldeep Bhui, Derek Rosario, Damien Ridge, Sheila Donovan, Ania Korszun, Paul Little, Adrienne Morgan, Olivier Quentin, Rebecca Roylance, Peter White, and Trudie Chalder
- Subjects
Acceptance and Commitment Therapy ,cancer survivor ,Quality of Life ,Pragmatic trial ,Medicine (General) ,R5-920 - Abstract
Abstract Background Two million people in the UK are living with or beyond cancer and a third of them report poor quality of life (QoL) due to problems such as fatigue, fear of cancer recurrence, and concerns about returning to work. We aimed to develop and evaluate an intervention based on acceptance and commitment therapy (ACT), suited to address the concerns of cancer survivors and in improving their QoL. We also recognise the importance of exercise and vocational activity on QoL and therefore will integrate options for physical activity and return to work/vocational support, thus ACT Plus (+). Methods We will conduct a multi-centre, pragmatic, theory driven, randomised controlled trial. We will assess whether ACT+ including usual aftercare (intervention) is more effective and cost-effective than usual aftercare alone (control). The primary outcome is QoL of participants living with or beyond cancer measured using the Functional Assessment of Cancer Therapy: General scale (FACT-G) at 52 weeks. We will recruit 344 participants identified from secondary care sites who have completed hospital-based treatment for cancer with curative intent, with low QoL (determined by the FACT-G) and randomise with an allocation ratio of 1:1 to the intervention or control. The intervention (ACT+) will be delivered by NHS Talking Therapies, specialist services, and cancer charities. The intervention consists of up to eight sessions at weekly or fortnightly intervals using different modalities of delivery to suit individual needs, i.e. face-to-face sessions, over the phone or skype. Discussion To date, there have been no robust trials reporting both clinical and cost-effectiveness of an ACT based intervention for people with low QoL after curative cancer treatment in the UK. We will provide high quality evidence of the effectiveness and cost-effectiveness of adding ACT+ to usual aftercare provided by the NHS. If shown to be effective and cost-effective then commissioners, providers and cancer charities will know how to improve QoL in cancer survivors and their families. Trial registration ISRCTN: ISRCTN67900293 . Registered on 09 December 2019. All items from the World Health Organization Trial Registration Data Set for this protocol can be found in Additional file 2 Table S1.
- Published
- 2024
- Full Text
- View/download PDF
33. Age at diagnosis and social risks among Black cancer survivors: Results from the Detroit Research on Cancer Survivors cohort.
- Author
-
Hastert, Theresa A., McDougall, Jean A., Robinson, Jamaica R. M., Palakshappa, Deepak, Seaton, Randell, Ruterbusch, Julie J., Beebe‐Dimmer, Jennifer L., and Schwartz, Ann G.
- Subjects
- *
POOR people , *CANCER survivors , *HOUSING stability , *MIDDLE age , *CANCER research - Abstract
Background: Social risks are common among cancer survivors who have the fewest financial resources; however, little is known about how prevalence differs by age at diagnosis, despite younger survivors' relatively low incomes and wealth. Methods: The authors used data from 3703 participants in the Detroit Research on Cancer Survivors (ROCS) cohort of Black cancer survivors. Participants self‐reported several forms of social risks, including food insecurity, housing instability, utility shut‐offs, not getting care because of cost or lack of transportation, and feeling unsafe in their home neighborhood. Modified Poisson models were used to estimate prevalence ratios and 95% confidence intervals (CIs) of social risks by age at diagnosis, controlling for demographic, socioeconomic, and cancer‐related factors. Results: Overall, 35% of participants reported at least one social risk, and 17% reported two or more risks. Social risk prevalence was highest among young adults aged 20–39 years (47%) followed by those aged 40–54 years (43%), 55–64 years (38%), and 65 years and older (24%; p for trend <.001). Compared with survivors who were aged 65 years and older at diagnosis, adjusted prevalence ratios for any social risk were 1.75 (95% CI, 1.42–2.16) for survivors aged 20–39 years, 1.76 (95% CI, 1.52–2.03) for survivors aged 40–54 years, and 1.41 (95% CI, 1.23–1.60) for survivors aged 55‐64 years at diagnosis. Similar associations were observed for individual social risks and experiencing two or more risks. Conclusions: In this population of Black cancer survivors, social risks were inversely associated with age at diagnosis. Diagnosis in young adulthood and middle age should be considered a risk factor for social risks and should be prioritized in work to reduce the financial effects of cancer on financially vulnerable cancer survivors. This report evaluates associations between age at diagnosis and the prevalence of social risks, such as food insecurity, housing instability, and forgoing care because of lack of transportation in a population‐based cohort of Black cancer survivors. Age at diagnosis was inversely associated with social risks, and young adult survivors reported the highest prevalence of any social risks, multiple social risks, and several individual social risks. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
34. Survey of Transitional Care Between Pediatrics and Obstetrics/Gynecology in Japan.
- Author
-
Nakamura, Kentaro, Terashita, Yukayo, Manabe, Atsushi, and Suzuki, Nao
- Subjects
- *
TUMORS in children , *OBSTETRICIANS , *RESEARCH funding , *QUESTIONNAIRES , *PHYSICIANS' attitudes , *DESCRIPTIVE statistics , *TRANSITIONAL care , *GYNECOLOGY , *SURVEYS , *PEDIATRICS , *GYNECOLOGISTS , *OBSTETRICS , *MEDICAL referrals - Abstract
Purpose: This study's aim was to determine the actual status of transitional care for patients with pediatric cancer (PPCs) in Japan by surveying obstetricians/gynecologists. Methods: A questionnaire survey on transitional medicine was conducted in the form of an online questionnaire at 579 major training facilities nationwide, which were registered with the Japanese Society of Obstetrics and Gynecology. Results: While 40% of the facilities had received referrals for PPCs, only 13% provided transitional care specifically for PPCs. The most common problems with referrals were related to "insufficient explanation." In addition, at facilities with no experience treating PPCs, many respondents commented that they did not know how to follow the progression of the disease. Regarding the necessity of obstetrics/gynecology visits for PPCs, more than half of the respondents at facilities with experience treating PPCs answered that such visits were "necessary"; only 1% answered that they were "unnecessary." On the other hand, 37% of the facilities that had no experience treating PPCs answered that it was "necessary," whereas 4% answered that it was "unnecessary." Conclusions: This survey of the actual status of transitional care between pediatrics and obstetrics/gynecology in Japan identified issues to be addressed for the spread of transitional care. The results suggest that, in the future, health care professionals need education to increase their knowledge, and that patient education that leads to patients' awareness of their own self-management is necessary. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
35. Closing the Gaps: Addressing the Unmet Needs of Cancer Survivors.
- Author
-
Loacker, Debra E., Shannon-Dorcy, Kathleen, Rajotte, Emily Jo, and Bartell, Joli
- Subjects
- *
PATIENT education , *SELF-efficacy , *MENTAL health , *CANCER , *HEALTH , *FUNCTIONAL status , *SPECIAL days , *NEEDS assessment , *CANCER patient psychology , *SOCIAL support , *WELL-being - Abstract
Moving Beyond Cancer to Wellness is a patientand caregiver-focused educational outreach event with an inspirational message and lectures that address common concerns among cancer survivors. This event is open to the community and offers a keynote speaker, breakout sessions on specific survivorship topics, and a patient panel. This typically in-person event was held virtually in 2020 and 2021 because of the COVID-19 pandemic, but returned to the in-person format in 2022. As demonstrated by consistently strong attendance and high satisfaction results, this communitybased educational event has been successful in communicating survivorship information to cancer survivors and their families. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
36. Oocyte collection and outcome following oncologic treatment: a retrospective multicentre study.
- Author
-
Fernández-González, Marta J., Borgmann-Staudt, Anja, Llagostera, Clara González, Ceballos-Garcia, Elena, Gebauer, Judith, Jantke, Andreas, Barnbrock, Anke, Kentenich, Heribert, Klco-Brosius, Stephanie, Lotz, Laura, and Balcerek, Magdalena
- Abstract
Purpose: This study assesses fertility treatment outcomes in female patients who had undergone successful oocyte retrieval following cancer therapy. Methods: Between January 2020 and December 2022, we collected fertility treatment data from six participating centres in Spain and Germany. All patients associated with this data had undergone successful oocyte retrieval following cancer treatment. Results: Women had most frequently been diagnosed with a haematological (41.9%), breast (22.6%) or gynaecological malignancy (12.9%); two thirds (67.7%) had previously received a chemotherapy, half a radiotherapy (53.3%) and 45.2% had undergone surgery. On average, 7 years (range 0–28) had passed between cancer treatment and first ovarian stimulation cycle. Forty-nine ovarian stimulation cycles had been conducted on these 31 women between 2004 and 2021 (mean age at first oocyte collection following treatment: 34.8 ± 5.7 years). On average, 7 oocytes were collected per cycle (range 0–26) and 11 were collected per patient (range 0–51). Out of the 190 oocytes collected for immediate use of artificial reproductive technique, 139 were fertilised at a rate of 73%. Live birth rate per fresh transfer was 45% (9/20); no births were reported following cryotransfer (0/10). Mean values of anti-Mullerian hormone (AMH) before stimulation declined with time since treatment; however, oocytes were successfully collected from four women with an AMH of <0.5 ng/ml, although no pregnancies were reported. Ten pregnancies were documented; 3 ended in miscarriage. Two twin and 5 single pregnancies resulted in nine live births. On average, children were carried to term. Conclusion: In this small cohort, oocytes were successfully collected after chemotherapy and radiotherapy, despite—in individual cases—low AMH values. Further studies are needed to enrich the database and ultimately provide appropriate counselling to female cancer patients regarding expectations and ART outcome following cancer therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
37. A systematic review and meta-analysis of e-cigarette use among cancer survivors.
- Author
-
Lopez-Olivo, Maria A., James, Justin, James, Joel, Krause, Kate J., Roth, Michael, Palos, Guadalupe R., Ma, Hilary, Rodriguez, Alma, Gilmore, Katherine, Cinciripini, Paul, and Suarez-Almazor, Maria E.
- Abstract
Purpose: We conducted a systematic review and meta-analysis to determine the use of e-cigarettes among cancer survivors, factors associated with their use, and prevalence of e-cigarette use as a quit attempt. Methods: We searched five electronic databases until June 2022. Two authors independently selected studies, appraised their quality, and collected data. Results: Twenty-three publications from eight data sources (national surveys) met our eligibility criteria. The pooled rate of lifetime e-cigarette use among cancer survivors was 15% (95% CI 6–27%); current use was 3% (95% CI 0–8%). Among survivors who currently used traditional cigarettes, 63% (95% CI 57–69%) also used e-cigarettes. The reported rates of weighted lifetime e-cigarette use differed between age groups (18–44 years, up to 46.7%; 45–64, up to 27.2%; ≥65, up to 24.8%). Nine publications reported factors associated with lifetime e-cigarette use (i.e., active use of traditional cigarettes; heavy drinking; poor mental health; younger age; being male, non-Hispanic White, or single; having less than high school education or income ≤$25,000 USD; and living in the South regions of the US or urban areas). E-cigarettes were used as a quit resource by 75% of survivors reporting dual use of electronic and traditional cigarettes (95% CI 63%, 85%). Conclusion: More than two-thirds of survivors currently using traditional cigarettes also use e-cigarettes. Higher use rates of e-cigarettes were reported among young cancer survivors compared to older survivors. Future studies are needed to assess the impact of e-cigarettes on long-term health and improve screening of smoking behaviors. Implications for Cancer Survivors: Our study provides an overview of the prevalence of e-cigarette use and sociodemographic risk factors associated with e-cigarette use among cancer survivors. The findings can assist providers in supporting attempts to quit among cancer survivors. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
38. Perception of a need to change weight in individuals living with and beyond breast, prostate and colorectal cancer: a cross-sectional survey.
- Author
-
Heuchan, Gabriella N., Lally, Phillippa J., Beeken, Rebecca J., Fisher, Abigail, and Conway, Rana E.
- Abstract
Purpose: People living with and beyond cancer (LWBC) are advised to achieve a body mass index (BMI) within the healthy range (≥ 18.5 and < 25). Not perceiving a need for weight change may be a barrier to achieving a healthy weight. This study aimed to explore factors associated with perceived need for weight change among people LWBC. Methods: Adults diagnosed with breast, prostate, or colorectal cancer were recruited through National Health Service sites in Essex and London. Participants (N = 5835) completed the 'Health and Lifestyle After Cancer' survey, which included a question on perceived need to change weight. Associations between perceived need for weight change and BMI, and perceived need for weight change and health and demographic variables, were analyzed using chi-square tests and logistic regression, respectively. Results: The proportion of participants perceiving a need to lose weight differed according to BMI category: healthy weight (23%), overweight (64%), obese (85%) (P < 0.001). Having overweight or obesity but not perceiving a need to lose weight was associated with being older, male, non-white, not married or cohabiting, and having cancer that had spread, no formal qualifications, no comorbidities, and having received chemotherapy. Conclusions: Perceived need to lose weight is prevalent among people LWBC with obesity and overweight. This group may be interested in weight management support. Demographic and health factors were associated with having obesity or overweight but not perceiving a need to lose weight. Implications for cancer survivors: Weight loss interventions for people LWBC are needed. A subset of people LWBC with overweight and obesity may need additional information or motivators to engage with weight management. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
39. A latent class analysis of health behavior changes after cancer diagnosis among Hispanic/Latino cancer survivors.
- Author
-
Noriega Esquives, Blanca S., St. George, Sara M., Moreno, Patricia I., Lee, Tae Kyoung, Munoz, Edgar, Lad, Thomas, Pollack, Alan, Hollowell, Courtney M. P., Ramirez, Amelie G., and Penedo, Frank J.
- Abstract
Purpose: We aimed to identify subgroups of Hispanic/Latino (H/L) cancer survivors with distinct health behavior patterns and their associated sociodemographic, medical, and psychosocial characteristics. Methods: Baseline data were used from a randomized clinical trial evaluating the efficacy of an enhanced patient navigation intervention in H/L cancer survivors. Participants (n = 278) completed the Lifestyle Behavior Scale and validated questionnaires on health-related quality of life (HRQOL), supportive care needs, distress, and satisfaction with cancer care. Latent class analysis was used to determine the latent classes and associated characteristics. Results: Three latent classes emerged: class 1 (survivors who increased health behaviors [e.g., exercising and eating healthy] since diagnosis); class 2 (no changes in health behaviors since diagnosis); and class 3 (a "mixed class," with a higher or lower engagement across various health behaviors since diagnosis). Participants in class 1 were significantly more educated and less likely to be foreign born. Participants in class 2 were significantly older and more likely to have prostate cancer. H/L cancer survivors in class 3 had a significantly lower income, were less educated, and reported greater unmet supportive care needs, more distress, and poorer HRQOL. Conclusions: Survivors who report engaging in health behaviors less frequently since diagnosis may be experiencing psychosocial challenges and health disparities. Implications for Cancer Survivors: Hispanic/Latino cancer survivors may benefit from screening for social determinants of health and mental health needs, prompt referral to supportive care services, community resources, and public services, and participating in culturally informed psychosocial interventions to address their unique needs. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
40. A comparison of chronic conditions and health characteristics between cancer survivors and non-cancer survivors.
- Author
-
Singh, Anjin, Gallaway, Michael Shayne, and Rascon, Addey
- Subjects
OBSTRUCTIVE lung disease diagnosis ,KIDNEY disease diagnosis ,ARTHRITIS diagnosis ,STROKE diagnosis ,HEALTH status indicators ,CORONARY disease ,RESEARCH funding ,LOGISTIC regression analysis ,HYPERTENSION ,CANCER patients ,DESCRIPTIVE statistics ,MULTIVARIATE analysis ,CHRONIC diseases ,COMPARATIVE studies ,CONFIDENCE intervals ,DEMOGRAPHY ,COMORBIDITY - Abstract
Objective: Cancer survivors have unique healthcare needs. An important consideration for survivorship is chronic diseases and health risk factors. The purpose of this study is to describe demographics, risk factors, and comorbid health conditions in adult cancer survivors. Method: We analyzed 2019 Arizona Behavioral Risk Factor Surveillance System data to compare cancer survivors to non-cancer survivors (aged 18 or older) to assess differences between the two populations. Adjusted and unadjusted population-based estimates and 95% confidence intervals were calculated, and multivariable logistic regression models were performed. Results: Eight thousand nine-hundred and twenty (8920) respondents (1007 survivors; 7913 non-cancer survivors) were included. Compared to non-cancer survivors, cancer survivors were more likely to be female, 65 years and older, non-Hispanic white, veterans, and less likely to be employed. Survivors had higher rates of coronary heart disease, stroke, chronic obstructive pulmonary disease, kidney disease, hypertension, arthritis, multiple chronic conditions, being overweight, and being a former smoker. Survivors were more likely to report fair/poor health than non-cancer survivors. Discussion: These findings can be used by healthcare and public health practitioners to evaluate the programmatic efforts and resources, implement targeted interventions toward cancer survivors, and improve health and quality of life. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
41. Infrared laser moxibustion for cancer-related fatigue in breast cancer survivors: a randomized controlled trial.
- Author
-
Mao, Huijuan, Jin, Ming, Xie, Lulu, Mao, Ni, Shen, Xubo, Chen, Junchao, Chen, Xuefen, Mao, Jun J., and Shen, Xueyong
- Subjects
CANCER fatigue ,INFRARED lasers ,MOXIBUSTION ,CANCER survivors ,BREAST cancer ,RANDOMIZED controlled trials ,FATIGUE (Physiology) - Abstract
Background: Cancer-related fatigue (CRF) is a pervasive, persistent, and distressing symptom experienced by cancer patients, for which few treatments are available. We investigated the efficacy and safety of infrared laser moxibustion (ILM) for improving fatigue in breast cancer survivors. Methods: A three-arm, randomized, sham-controlled clinical trial (6-week intervention plus 12-week observational follow-up) was conducted at a tertiary hospital in Shanghai, China. The female breast cancer survivors with moderate to severe fatigue were randomized 2:2:1 to ILM (n = 56) sham ILM (n = 56), and Waitlist control (WLC)(n = 28) groups. Patients in the ILM and sham ILM (SILM) groups received real or sham ILM treatment, 2 sessions per week for 6 weeks, for a total of 12 sessions. The primary outcome was change in the Brief Fatigue Inventory (BFI) score from baseline to week 6 with follow-up until week 18 assessed in the intention-to-treat population. Results: Between June 2018 and July 2021, 273 patients were assessed for eligibility, and 140 patients were finally enrolled and included in the intention-to-treat analysis. Compared with WLC, ILM reduced the average BFI score by 0.9 points (95% CI, 0.3 to 1.6, P =.007) from baseline to week 6, with a difference between the groups of 1.1 points (95% CI, 0.4 to 1.8, P =.002) at week 18. Compared with SILM, ILM treatment resulted in a non-significant reduction in the BFI score (0.4; 95% CI, -0.2 to 0.9, P =.206) from baseline to week 6, while the between-group difference was significant at week 18 (0.7; 95% CI, 0.2 to 1.3, P =.014). No serious adverse events were reported. Conclusion: While ILM was found to be safe and to significantly reduce fatigue compared with WLC, its promising efficacy against the sham control needs to be verified in future adequately powered trials. Trial registration: Clinicaltrials.gov: NCT04144309. Registered 12 June 2018. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
42. Association of metabolic health and obesity with coronary heart disease in adult cancer survivors.
- Author
-
Kim, Kyuwoong, Di Giovanna, Edvige, Jung, Hyeyun, Bethineedi, Lakshimi Deepak, Jun, Tae Joon, and Kim, Young‐Hak
- Subjects
- *
CANCER survivors , *CANCER patients , *CORONARY disease , *PROPORTIONAL hazards models , *NATIONAL health insurance - Abstract
Background: The metabolically healthy obese (MHO) phenotype is associated with an increased risk of coronary heart disease (CHD) in the general population. However, association of metabolic health and obesity phenotypes with CHD risk in adult cancer survivors remains unclear. We aimed to investigate the associations between different metabolic health and obesity phenotypes with incident CHD in adult cancer survivors. Methods: We used National Health Insurance Service (NHIS) to identify a cohort of 173,951 adult cancer survivors aged more than 20 years free of cardiovascular complications. Metabolically healthy nonobese (MHN), MHO, metabolically unhealthy nonobese (MUN), metabolically unhealthy obese (MUO) phenotypes were created using as at least three out of five metabolic health criteria along with obesity (body mass index ≥ 25.0 kg/m2). We used Cox proportional hazards model to assess CHD risk in each metabolic health and obesity phenotypes. Results: During 1,376,050 person‐years of follow‐up, adult cancer survivors with MHO phenotype had a significantly higher risk of CHD (hazard ratio [HR] = 1.52; 95% confidence intervals [CI]: 1.41 to 1.65) as compared to those without obesity and metabolic abnormalities. MUN (HR = 1.81; 95% CI: 1.59 to 2.06) and MUO (HR = 1.92; 95% CI: 1.72 to 2.15) phenotypes were also associated with an increased risk of CHD among adult cancer survivors. Conclusions: Adult cancer survivors with MHO phenotype had a higher risk of CHD than those who are MHN. Metabolic health status and obesity were jointly associated with CHD risk in adult cancer survivors. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
43. Previous cancers in women diagnosed with premature ovarian insufficiency: A nationwide population‐based case–control study.
- Author
-
Silvén, Heidi, Savukoski, Susanna M., Pesonen, Paula, Niinimäki, Riitta, Pukkala, Eero, Gissler, Mika, Suvanto, Eila, and Niinimäki, Maarit
- Subjects
- *
PREMATURE ovarian failure , *CANCER patients , *HORMONE therapy , *CANCER diagnosis , *CASE-control method , *CANCER fatigue - Abstract
Introduction: To investigate the occurrence of previous cancer diagnoses in women suffering from premature ovarian insufficiency (POI) and compare it with the general population, shedding light on the association between cancer, cancer treatments, and POI. Material and methods: We conducted a nationwide case–control study based on registry data from various sources, including the Social Insurance Institution, Finnish Population Information System, and Finnish Cancer Registry spanning from 1953 to 2018. Our participants comprised all women in Finland who, between 1988 and 2017, received hormone replacement therapy reimbursement for ovarian insufficiency before the age of 40 years (n = 5221). Controls, matched in terms of age and municipality of residence, were selected from the Finnish Population Information System (n = 20 822). Our main exposure variable was a history of cancer diagnosis preceding the diagnosis of POI. We analyzed odds ratios (OR) to compare the prevalence of previous cancers in women with POI with that in controls, stratifying results based on cancer type, age at cancer diagnosis, and the time interval between cancer diagnosis and POI. We also assessed changes in OR for previous cancer diagnoses over the follow‐up period. Results: Out of the women diagnosed with POI, 21.9% had previously been diagnosed with cancer, resulting in an elevated OR of 36.5 (95% confidence interval [CI] 30.9 to 43.3) compared with 0.8% of the controls. The risk of developing POI was most pronounced during the first 2 years following a cancer diagnosis, with an OR of 103 (95% CI 74.1 to 144). Importantly, this risk remained elevated even when the time interval between cancer and POI exceeded 10 years, with an OR of 5.40 (95% CI 3.54 to 8.23). Conclusions: This study reveals that 21.9% of women with POI have a history of cancer, making the prevalence of cancer among these women 27.5 times higher than age‐matched controls in the Finnish population. The risk of developing POI is most substantial in the first 2 years following a cancer diagnosis. These findings underscore the role of cancer treatments as an etiological factor for POI and emphasize the importance of recognizing the risk of POI in cancer survivors for early diagnosis and intervention. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
44. Metabolic Syndrome According to Dietary and Health-Related Lifestyle in Male Cancer Survivors and Non-Cancer over 40 Years of Age.
- Author
-
Meng, Huan, Choi, Yongchul, and Yim, Kitae
- Subjects
CANCER survivors ,METABOLIC syndrome ,DIETARY patterns ,MULTIPLE regression analysis ,LOGISTIC regression analysis ,FAT - Abstract
Researchers often report higher metabolic syndrome (MetS) pr\4;evalence among cancer survivors than among non-cancer individuals. This study aims to explore the impact of cancer presence, activity type, and dietary lifestyle on MetS in males over 40 years of age. Participants (n = 9846; 618 cancer survivors, 9228 non-cancer) were selected by extracting data from a Korean government database spanning the years 2016 to 2021. Physical activity patterns, dietary habits, and MetS factors were measured, and a multiple logistic regression analysis was statistically processed for an odds ratio (OR). MetS was present in 32.8% of cancer survivors and 28.6% of non-cancer individuals. Gastric cancer survivors exhibited a 16% lower OR for MetS versus non-cancer participants. The ORs were higher by 1.60-, 1.45-, and 1.26-fold for colorectal, urinary, and other cancers, respectively. Cancer survivors with high calorie, carbohydrate, and fat intakes exhibited ORs of 2.01 (95% CI 1.28−4.04), 2.33 (95% CI 1.28−4.54), and 1.39 (95% CI 1.05−2.37) compared to the recommended level. The high fiber-intake group reduced the MetS OR by 20%. In conclusion, The MetS prevalence was higher in survivors with colorectal cancer, urinary cancer, and other cancers, while it was lower in patients with gastric cancer. Survivors with low rates of eating three meals a day, high skipping breakfast, increased eating-out rate, and no nutritional learning opportunity displayed higher MetS prevalence. Additionally, cancer survivors who had more strength and leisure activities had a lower OR of MetS. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
45. A data-driven approach to improve wellness and reduce recurrence in cancer survivors.
- Author
-
Hariharan, Ramkumar, Hood, Leroy, and Price, Nathan D.
- Subjects
CANCER survivors ,CANCER relapse ,DISEASE relapse ,QUALITY of life - Abstract
For many cancer survivors, toxic side effects of treatment, lingering effects of the aftermath of disease and cancer recurrence adversely affect quality of life (QoL) and reduce healthspan. Data−driven approaches for quantifying and improving wellness in healthy individuals hold great promise for improving the lives of cancer survivors. The data-driven strategy will also guide personalized nutrition and exercise recommendations that may help prevent cancer recurrence and secondary malignancies in survivors. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
46. Study protocol for a pragmatic randomised controlled trial of comparing enhanced acceptance and commitment therapy plus (+) added to usual aftercare versus usual aftercare only, in patients living with or beyond cancer: SUrvivors' Rehabilitation Evaluation after CANcer (SURECAN) trial
- Author
-
Khan, Imran, Taylor, Stephanie J. C., Robinson, Clare, Moschopoulou, Elisavet, McCrone, Paul, Bourke, Liam, Thaha, Mohamed, Bhui, Kamaldeep, Rosario, Derek, Ridge, Damien, Donovan, Sheila, Korszun, Ania, Little, Paul, Morgan, Adrienne, Quentin, Olivier, Roylance, Rebecca, White, Peter, and Chalder, Trudie
- Subjects
- *
ACCEPTANCE & commitment therapy , *RANDOMIZED controlled trials , *CANCER survivors , *PATIENT aftercare , *RESEARCH protocols - Abstract
Background: Two million people in the UK are living with or beyond cancer and a third of them report poor quality of life (QoL) due to problems such as fatigue, fear of cancer recurrence, and concerns about returning to work. We aimed to develop and evaluate an intervention based on acceptance and commitment therapy (ACT), suited to address the concerns of cancer survivors and in improving their QoL. We also recognise the importance of exercise and vocational activity on QoL and therefore will integrate options for physical activity and return to work/vocational support, thus ACT Plus (+). Methods: We will conduct a multi-centre, pragmatic, theory driven, randomised controlled trial. We will assess whether ACT+ including usual aftercare (intervention) is more effective and cost-effective than usual aftercare alone (control). The primary outcome is QoL of participants living with or beyond cancer measured using the Functional Assessment of Cancer Therapy: General scale (FACT-G) at 52 weeks. We will recruit 344 participants identified from secondary care sites who have completed hospital-based treatment for cancer with curative intent, with low QoL (determined by the FACT-G) and randomise with an allocation ratio of 1:1 to the intervention or control. The intervention (ACT+) will be delivered by NHS Talking Therapies, specialist services, and cancer charities. The intervention consists of up to eight sessions at weekly or fortnightly intervals using different modalities of delivery to suit individual needs, i.e. face-to-face sessions, over the phone or skype. Discussion: To date, there have been no robust trials reporting both clinical and cost-effectiveness of an ACT based intervention for people with low QoL after curative cancer treatment in the UK. We will provide high quality evidence of the effectiveness and cost-effectiveness of adding ACT+ to usual aftercare provided by the NHS. If shown to be effective and cost-effective then commissioners, providers and cancer charities will know how to improve QoL in cancer survivors and their families. Trial registration: ISRCTN: ISRCTN67900293. Registered on 09 December 2019. All items from the World Health Organization Trial Registration Data Set for this protocol can be found in Additional file 2 Table S1. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
47. Female cancer survivors: sexual function, psychological distress, and remaining fertility.
- Author
-
Reiser, Elisabeth, Böttcher, Bettina, Ossig, Charlotte, Schiller, Julia, Tollinger, Susanne, and Toth, Bettina
- Subjects
- *
CANCER survivors , *PSYCHOLOGICAL distress , *FERTILITY , *FERTILITY preservation , *OVARIAN reserve , *MENSTRUAL cycle - Abstract
Purpose: Improved survivorship in cancer patients leads to new challenging issues including potential impairment of quality of life, sexual function, and fertility. The aim of this study was to assess sexual dysfunction (SD) and psychological distress in female cancer survivors who underwent fertility preservation in the past in comparison to reviewed healthy control data from other published studies. Additionally, our focus was on the difference in SD between women with current desire to get pregnant and already completed family planning. Methods: In this prospective study, 53 female cancer survivors who underwent fertility preservation at time of cancer diagnosis between 2010 and 2020 were invited to a gynecological exam, laboratory assessment, and two questionnaires (Female Sexual Function Index (FSFI) and Hospital anxiety and depression scale (HADS)) in 2022. These scores were compared to results in the literature of healthy controls and depending on anti-Mullerian-hormone (AMH) levels, current desire to have a child, and age. Results: After a mean follow-up time of 70 ± 50 months, SD was detected in 60.4% (n = 32) of the 53 included patients. Normal results regarding HADS-D/anxiety and HADS-D/depression were found in 88.7% and 94.3% of patients, respectively. At time of follow-up, 69.9% (n = 40) regained regular menstrual cycles, 52.6% (n = 20) < 40 years showed a diminished ovarian reserve with AMH levels < 1.1 ng/ml and 28.3% (n = 15) suffered from infertility. Conclusion: Female cancer survivors may be at risk for SD. Cancer patients should be informed about possible sexual dysfunction already at the start of cancer treatment and during follow-up. In addition, contraception needs to be addressed if regular cycles occur as more than two-thirds of the women regained regular menstrual cycles. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
48. The use of fertility treatments among reproductive-aged women after cancer.
- Author
-
Kipling, Lauren M., Shandley, Lisa M., Mertens, Ann C., Spencer, Jessica B., and Howards, Penelope P.
- Abstract
To examine whether female cancer survivors are more likely to pursue care for infertility after cancer than women without cancer. Population-based cohort study involving detailed interviews regarding reproductive history. Not applicable. Female cancer survivors aged 22–45 years, who were at least 2 years after a cancer diagnosis between the ages of 20 and 35 years (n = 1,036), and age-matched comparison women with no cancer history (n = 1,026). History of cancer vs. no history of cancer. Each cancer survivor was randomly matched to a comparison woman, who was assigned an artificial age at cancer diagnosis equal to that of her match. Matching was repeated 1,000 times. Outcomes of visiting a doctor for help becoming pregnant or undergoing fertility treatment were modeled using Cox proportional hazards regression, comparing survivors after a cancer diagnosis to age-matched comparison women, adjusted for race, income, residence, education, and parity. Only 25.5% of cancer survivors reported meeting their desired family size before a cancer diagnosis. The median time from diagnosis to interview among survivors was 7 (interquartile range 5–11) years. Cancer survivors were more likely to report having no children (32.6%) at the interview compared with women with no cancer history (19.5%). Survivors were not more likely to visit a doctor for help becoming pregnant compared with women without a cancer history, matched on birth year and followed by the age at which cancer survivors received their diagnosis (hazard ratio [HR] 1.16, 95% simulation interval [SI] 0.78–1.74). Compared with cancer-free women, cancer survivors had similar probabilities of pursuing any treatment (adjusted HR [aHR] 0.88, 95% SI 0.46–1.56), using hormones or medications (aHR 0.86, 95% SI 0.46–1.63), or undergoing intrauterine insemination (aHR 1.26, 95% SI 0.40–5.88) to conceive. Cancer survivors were slightly more likely to pursue surgical interventions to become pregnant (HR 1.55, 95% SI 0.67–3.71). Of those who visited a doctor but declined to pursue fertility treatment, one-quarter of women reported declining treatment due to cost. Cancer survivors did not use fertility treatments at higher rates than the general population. Further counseling and education surrounding fertility options are recommended for young adult female cancer patients after treatment is completed. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
49. Utilization of sperm cryopreservation in patients with testicular cancer.
- Author
-
Menzel, Viktoria, Richter, Emilia, Helke, Charlotte, Bürk, Björn Thorben, Erb, Holger H. H., Leike, Steffen, Borkowetz, Angelika, Thomas, Christian, and Baunacke, Martin
- Abstract
Purpose: We assessed factors that affect the utilization of sperm cryopreservation before 2021, when patients covered expenses, and the influence on quality of life. Methods: Between 2011 and 2021, testicular cancer survivors (TCS) at our clinic completed a questionnaire, including EORTC QLQ-TC26, covering sperm cryopreservation, sociodemographic details, post-treatment births, and artificial insemination. Results: After 5.7 ± 3.0 years, 279 participants (64%) responded to the questionnaire. Among them, 33% (91/279) of testicular cancer survivors chose sperm cryopreservation prior to treatment, with 11% (10/91) using it for insemination. Conversely, 2% (3/188) without cryopreservation reported unfulfilled desire to have children. Univariate analysis showed TCS with cryopreservation were younger (30.6 ± 7.1 (35 (21–59)) vs. 42.4 ± 10.9 (48 (22–81)) years; p = 0.001), had a lower BMI (24.2 ± 3.3 vs. 26.6 ± 4.6 kg/m2; p = 0.009) and a lower Charlson Score (> 3: 36% vs. 60%; p < 0.001). Multivariate analysis revealed older age (≥ 37 years: OR 13.1 (5.5–31.2), p < 0.001) and lower education (middle school or less: OR 3.3 (1.6–6.9), p = 0.001) as independent factors associated with not undergoing cryopreservation. Regarding quality of life, multivariate analysis identified a lower infertility anxiety score (OR 4.3 (2.0–9.0), p < 0.001) and higher age (≥ 44 years: OR 5.4 (2.6–11.3); p < 0.001) as predictors for the absence of prior cryopreservation. Conclusions: Age and education seem to impact the choice of undergoing paid sperm cryopreservation. Urologists should inform testicular cancer patients about costs and coverage. Importantly, the occurrence of unmet desires for parenthood is minimal among those who forego cryopreservation. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
50. Accuracy of patient race and ethnicity data in a central cancer registry.
- Author
-
Codden, Rachel R., Sweeney, Carol, Ofori-Atta, Blessing S., Herget, Kimberly A., Wigren, Kacey, Edwards, Sandra, Carter, Marjorie E., McCarty, Rachel D., Hashibe, Mia, Doherty, Jennifer A., and Millar, Morgan M.
- Subjects
RACE ,ETHNICITY ,RACIAL classification ,RACE relations ,ALASKA Natives - Abstract
Purpose: Race and Hispanic ethnicity data can be challenging for central cancer registries to collect. We evaluated the accuracy of the race and Hispanic ethnicity variables collected by the Utah Cancer Registry compared to self-report. Methods: Participants were 3,162 cancer survivors who completed questionnaires administered in 2015–2022 by the Utah Cancer Registry. Each survey included separate questions collecting race and Hispanic ethnicity, respectively. Registry-collected race and Hispanic ethnicity were compared to self-reported values for the same individuals. We calculated sensitivity and specificity for each race category and Hispanic ethnicity separately. Results: Survey participants included 323 (10.2%) survivors identifying as Hispanic, a lower proportion Hispanic than the 12.1% in the registry Hispanic variable (sensitivity 88.2%, specificity 96.5%). For race, 43 participants (1.4%) self-identified as American Indian or Alaska Native (AIAN), 32 (1.0%) as Asian, 23 (0.7%) as Black or African American, 16 (0.5%) Pacific Islander (PI), and 2994 (94.7%) as White. The registry race variable classified a smaller proportion of survivors as members of each of these race groups except White. Sensitivity for classification of race as AIAN was 9.3%, Asian 40.6%, Black 60.9%, PI 25.0%, and specificity for each of these groups was > 99%. Sensitivity and specificity for White were 98.8% and 47.4%. Conclusion: Cancer registry race and Hispanic ethnicity data often did not match the individual's self-identification. Of particular concern is the high proportion of AIAN individuals whose race is misclassified. Continued attention should be directed to the accurate capture of race and ethnicity data by hospitals. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.